The antiviral drug favipiravir will be investigated as a treatment for COVID-19 in people recovering at home and in other non-hospital settings, in a clinical trial funded and supported by the NIHR.
An NIHR supported study into the effects of a vegan diet in people with or at risk of developing type 2 diabetes has found that a plant-based lifestyle may help control blood glucose levels.
The NIHR has announced the fourth phase of the School for Primary Care Research (SPCR), with a refreshed membership and a new focus on supporting the full spectrum of primary care research and building research capacity.
NIHR and partner organisations across the health research ecosystem have today welcomed the publication of a bold and ambitious vision for the future of clinical research delivery in the UK.
A home-based parenting programme to prevent childhood behaviour problems, which unusually focuses on children when they are still just toddlers, has proven highly successful in its first public health trial funded by the NIHR.
A new NIHR-funded study will investigate whether Cognitive Behavioural Therapy (CBT) could help reduce the worryingly high number of children who are afraid of the dentist.
The NIHR has published its latest annual report highlighting its milestones and achievements during 2019/20.
Research published by the NIHR-funded Cochrane Tobacco Addiction Group today will reassure people who want to stop smoking that quitting for at least 6 weeks may improve their mental wellbeing, by reducing anxiety, depression, and stress.
An NIHR national specialty lead, Professor Peter Goadsby, is one of a group of four neuroscientists to receive this year’s The Brain Prize - one of the world’s most prestigious awards in neuroscience.
NIHR-funded research published this week, finds no overall effect of statins on the frequency or severity of muscle symptoms in people who had previously reported severe muscle symptoms when taking statins.
Vaccination has been linked to a substantial reduction in the risk of Covid-19 admissions to Scotland’s hospitals, landmark research suggests.
The NIHR and UK Research and Innovation (UKRI) have funded four new research studies to better understand and address the longer term effects of COVID-19 on physical and mental health.
Oxford University extends COVID-19 vaccine study to children
The NIHR-supported RECOVERY trial has shown that tocilizumab - an anti-inflammatory rheumatoid arthritis treatment - reduces the risk of death for hospitalised patients with severe COVID-19.
NIHR-supported researchers have created a new data tool to enable local authorities and the NHS to deliver targeted responses into communities at higher risk to COVID-19.
The NIHR has awarded funding to the University of Liverpool and Alder Hey Children’s Hospital to conduct a trial to improve the lives of people with cystic fibrosis (CF).
The NIHR-supported RECOVERY trial has begun investigating the anti-inflammatory arthritis drug, baricitinib, as a potential treatment for hospitalised COVID-19 patients.
The NIHR-supported Novavax COVID-19 vaccine, developed by the US-based biotechnology firm, is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data.
The NIHR Academy has launched a pilot pre-doctoral fellowship scheme for those working in local authorities and local authority supporting services.
The NIHR published a Framework on 21 May 2020 - when the NHS started to restore routine clinical services - to support the restarting of research paused due to COVID-19. This is the final update.
The NIHR has funded four new research projects to support patients with serious mental health problems detained under the Mental Health Act.
A new trial funded by NIHR will look at reducing the transmission of Covid-19 and its severity in care homes.
The NIHR-supported PRINCIPLE trial has found that the commonly used antibiotics, azithromycin and doxycycline, do not reduce recovery time for patients.
A high number of NHS staff injuries caused by slips and falls in the workplace could be prevented if staff were recommended to wear ultra-grip shoes as part of their uniform, according to NIHR-funded research.
The NIHR Clinical Research Network (CRN) has appointed Dr Kate Jones as the new national Research Delivery Director.
